Progyny Inc (PGNY)
16.80
+0.08
(+0.48%)
USD |
NASDAQ |
Sep 27, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Progyny SG&A Expense (Annual): 176.62M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 176.62M |
December 31, 2022 | 143.98M |
December 31, 2021 | 79.80M |
December 31, 2020 | 61.71M |
Date | Value |
---|---|
December 31, 2019 | 35.83M |
December 31, 2018 | 22.89M |
December 31, 2017 | 18.40M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
35.83M
Minimum
2019
176.62M
Maximum
2023
99.59M
Average
79.80M
Median
2021
SG&A Expense (Annual) Benchmarks
Delcath Systems Inc | 22.11M |
Star Equity Holdings Inc | 14.54M |
Exact Sciences Corp | 1.620B |
Illumina Inc | 1.612B |
CytoSorbents Corp | 37.87M |